Trial · NCT05744635
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pharmacokinetic profile TL | 12 months | To compare the trough level (TL) of different tacrolimus containing medications to Envarsus at each visit |
| Primary | Pharmacokinetic profile TDD | 12 months | To compare the total daily dose (TDD) of different tacrolimus containing medications to Envarsus at each visit |
| Primary | Pharmacokinetic profile C/D | 12 months | To compare the ration of TL and TDD (C/D) of different tacrolimus containing medications to Envarsus at each visit |
| Secondary | Liver function GGT | 12 months | Changes in Gamma glutamine transferase (GGT) levels compared to baseline. |
| Secondary | Liver function AP | 12 months | Changes in Alcalic phosphatase (AP) levels compared to baseline. |
| Secondary | Liver function GOT | 12 months | Changes in Glutamyl oxaloacetic transaminase (GOT) levels compared to baseline. |
| Secondary | Liver function GPT | 12 months | Changes in Glutamyl pyruvic transaminase (GPT) levels compared to baseline. |
| Secondary | Renal function | 12 months | Change in the estimated glomerular filtration rate (eGFR) compared to baseline. |
| Secondary | Kinetics and function | 12 months | To assess the possible relation of liver function parameters and eGFR to C/D (blood concentration and daily dosage) |
| Secondary | Rejection | 12 months | Incidence of acute graft rejection during the study |
| Secondary | Virus infection | 12 months | Incidence of BK and cytomegalovirus (CMV) infection during the study |
| Secondary | Variability | 12 months | To assess the intraindividual variability of the TL, TDD and the ratios of these parameters (C/D) |
| Secondary | Adherence BAASIS | 12 months | To assess the patient-adherence of therapy based on the BAASIS questionnaire |
| Secondary | Adherence prescriptions | 12 months | To assess the patient-adherence of therapy based on the prescription filled by individual patients, based on electronic health-care record. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05744635/registered